Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

• Bruno Vincenzi ,

  * E-mail: antonio.russo@usa.net (AR); b.vincenzi@unicampus.it (BV)

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Massimo Di Maio,

  Affiliations Clinical Trials Unit, National Cancer Institute, Naples, Italy, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano (TO), Italy

  ⨯
• Marianna Silletta,

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Loretta D’Onofrio,

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Chiara Spoto,

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Maria Carmela Piccirillo,

  Affiliation Clinical Trials Unit, National Cancer Institute, Naples, Italy

  ⨯
• Gennaro Daniele,

  Affiliation Clinical Trials Unit, National Cancer Institute, Naples, Italy

  ⨯
• Francesca Comito,

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Eliana Maci,

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Giuseppe Bronte,

  Affiliation Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy

  ⨯
• Antonio Russo ,

  * E-mail: antonio.russo@usa.net (AR); b.vincenzi@unicampus.it (BV)

  Affiliation Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy

  ⨯
• Daniele Santini,

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯
• Francesco Perrone,

  Affiliation Clinical Trials Unit, National Cancer Institute, Naples, Italy

  ⨯
• Giuseppe Tonini

  Affiliation Medical Oncology, University Campus Bio-Medico, Rome, Italy

  ⨯